Laboratoires Thea SA - Company Profile
Powered by 
All the data and insights you need on Laboratoires Thea SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Laboratoires Thea SA Strategy Report
- Understand Laboratoires Thea SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Laboratoires Thea SA (Thea) is a manufacturer of preventive and curative ophthalmologic products. The company develops, manufactures, and markets products such as eye drops, ophthalmic gels, sterile compresses, and micellar solutions in the areas of diagnosis, surgery and therapeutics. The company provides a wide range of products, both preventive and curative, in the fields of diagnosis, surgery and therapeutics.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company invests in R&D activities to pioneer new generations of products. It aims to intensify the development of innovative treatments for indications such as dry eye, glaucoma, allergy, palpebral conditions, ocular infections, ocular surgery, and violations of the posterior segment. The company supports the Alienor study, one of the epidemiological studies in collaboration with INSERM U897 Epidemiology and Biostatistics; and the Department of Ophthalmology of the University Hospital of Bordeaux. It also seeks partnerships, signing licensing agreements with researchers, universities, and pharmaceutical or biotechnological companies including Ophta Biotech and Institut de la Vision.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer